ZimVie (NASDAQ:ZIMV) Upgraded to "Strong-Buy" at Wall Street Zen

Wall Street Zen upgraded shares of ZimVie (NASDAQ:ZIMV - Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday.

ZIMV has been the topic of a number of other research reports. Needham & Company LLC restated a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley began coverage on ZimVie in a research note on Thursday, April 10th. They set a "buy" rating and a $16.00 price target on the stock. Finally, UBS Group reduced their price objective on ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a research note on Thursday, May 15th.

ZimVie Trading Up 2.9%

ZIMV stock traded up $0.26 during mid-day trading on Friday, reaching $9.26. The company's stock had a trading volume of 276,887 shares, compared to its average volume of 195,131. ZimVie has a 12 month low of $8.15 and a 12 month high of $22.40. The company has a current ratio of 2.14, a quick ratio of 1.48 and a debt-to-equity ratio of 0.58. The business's 50 day moving average price is $8.99 and its 200 day moving average price is $11.40. The company has a market cap of $257.89 million, a price-to-earnings ratio of -13.04 and a beta of 2.10.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.06. The company had revenue of $112.00 million during the quarter, compared to analyst estimates of $113.10 million. ZimVie had a negative net margin of 4.40% and a positive return on equity of 5.53%. On average, equities research analysts predict that ZimVie will post 0.6 EPS for the current year.

Institutional Investors Weigh In On ZimVie

Hedge funds and other institutional investors have recently made changes to their positions in the business. AlphaQuest LLC lifted its position in ZimVie by 2,695.9% in the 1st quarter. AlphaQuest LLC now owns 8,947 shares of the company's stock valued at $97,000 after acquiring an additional 8,627 shares in the last quarter. Quantbot Technologies LP purchased a new stake in shares of ZimVie in the first quarter worth approximately $98,000. Jones Financial Companies Lllp lifted its holdings in shares of ZimVie by 9,039.1% in the first quarter. Jones Financial Companies Lllp now owns 12,612 shares of the company's stock valued at $136,000 after purchasing an additional 12,474 shares in the last quarter. Hsbc Holdings PLC purchased a new position in shares of ZimVie during the first quarter valued at approximately $144,000. Finally, Wealth Enhancement Advisory Services LLC boosted its position in shares of ZimVie by 5.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company's stock valued at $211,000 after buying an additional 836 shares during the last quarter. 95.63% of the stock is owned by institutional investors.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.